Table 1 Demographics
Demographics | n (%) |
|---|---|
Total patients | 43 |
Median age (year) | 74 |
Gender | |
 Male | 23 (53.5) |
 Female | 20 (46.5) |
Anticoagulation | Â |
 Rivaroxaban | 21 (48.8) |
 Apixaban | 22 (51.2) |
 Edoxaban | 0 |
Indication for anticoagulation | |
 Atrial fibrillation | 30 (69.8) |
 DVT/PE | 9 (20.9) |
 Atrial fibrillation and DVT/PE | 3 (7.0) |
 Lower extremity venous bypass graft | 1 (2.3) |
Indication for anticoagulation reversal | |
 Gastrointestinal bleeding | 17 (39.5) |
 Intracranial hemorrhage—non-traumatic | 9 (20.9) |
 Intracranial hemorrhage—traumatic | 7 (16.3) |
 Trauma | 5 (14.0) |
 Other | 5 (11.6) |
Invasive procedure after 4F-PCC administration | 30 (69.8) |
 Gastrointestinal endoscopies | 16 (37.2) |
 Interventional radiology embolization/coiling | 3 (7.0) |
 Craniotomy | 3 (7.0) |
 Orthopedic | 3 (7.0) |
 Other | 5 (11.6) |